Araştırma Makalesi
BibTex RIS Kaynak Göster
Yıl 2023, Vetexpo-2022, 172 - 172, 05.01.2023

Öz

Acute respiratory injury model in rats

Yıl 2023, Vetexpo-2022, 172 - 172, 05.01.2023

Öz

Aim: Acute respiratory distress syndrome (ARDS) can develop as a result of many diseases and It causes a high rate of death. Research on treatment is still continuing. Thats why, we aimed to create an acute respiratory tract injury model with low mortality risk in rats. Material and method: Three 160 gr Winstar Hannover male rats were used in the prestudy. One of the rats was left as a control and was sacrificed. The other two were intubated and intratracheal lipopolysaccharide (LPS) administered. One of the rats which LPS was applied was sacrificed 6 hours and the other 12 hours later, and the lungs, brain, heart, kidney, liver and intestines were examined histopathologically. Results: In both of the rats treated with LPS, inflammation was observed in the peribronchial areas, which decreased more intensely towards the periphery of the lung. However, it was noted that inflammation was more intense in the lung of the rat, which was sacrificed after 12 hours. No pathological findings were detected in other organs. Conclusion: In the LPS-induced acute respiratory tract injury model, the lung periphery remains intact, allows a controlled, local inflammation, and doesn’t affect other organs, significantly reducing the mortality risk of the subjects. This model’s feature is important for the sustainability of research.

Toplam 0 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Veteriner Cerrahi
Bölüm Araştırma Makaleleri
Yazarlar

Şule Özsoy Bu kişi benim

Banu Karakuş Yılmaz 0000-0002-6661-4967

Duygu Sultan Oran Bu kişi benim 0000-0002-1453-3751

Yayımlanma Tarihi 5 Ocak 2023
Yayımlandığı Sayı Yıl 2023 Vetexpo-2022

Kaynak Göster

APA Özsoy, Ş., Karakuş Yılmaz, B., & Sultan Oran, D. (2023). Acute respiratory injury model in rats. Journal of Istanbul Veterinary Sciences172-172.

Bu dergi Creative Commons attribution 4.0 international  (CC-BY 4.0). lisansı ile lisanslanmıştır.